Necrolytic migratory erythema in a patient with neuroendocrine carcinoma
Necrolytic migratory erythema is an obligatory paraneoplastic syndrome. Here we describe a patient with a neuroendocrine tumor of probably pancreatic origin. She developed the typical skin lesions under chemotherapy with temozolomide and capecitabine.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2013
|
| In: |
Internal medicine
Year: 2013, Volume: 52, Issue: 1, Pages: 151-152 |
| ISSN: | 1349-7235 |
| DOI: | 10.2169/internalmedicine.52.8499 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2169/internalmedicine.52.8499 |
| Author Notes: | Michaela Gronau, Dirk Jäger, Alexander H. Enk and Jessica C. Hassel |
| Summary: | Necrolytic migratory erythema is an obligatory paraneoplastic syndrome. Here we describe a patient with a neuroendocrine tumor of probably pancreatic origin. She developed the typical skin lesions under chemotherapy with temozolomide and capecitabine. |
|---|---|
| Item Description: | Gesehen am 10.03.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1349-7235 |
| DOI: | 10.2169/internalmedicine.52.8499 |